1310 Chesapeake Terrace
United States - Map
Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. Its CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during the procedure, as well as enables delivery of precise, high dose radiation while patients breathe normally. The company also offers the TomoTherapy System, which consists of an integrated and versatile radiation therapy system used for the treatment of a range of cancer types. Accuray Incorporated markets its products in the United States directly, as well as through a sales agent and group purchasing organizations; and directly and through distributors in Europe, Japan and rest of Asia, South America, and internationally to hospitals and stand-alone treatment facilities. The company was incorporated in 1990 and is headquartered in Sunnyvale, California.
|Accuray Incorporated’s ISS Governance QuickScore as of Oct 1, 2014 is 5. The pillar scores are Audit: 5; Board: 3; Shareholder Rights: 5; Compensation: 7.|
|Brought to you by Institutional Shareholder Services (ISS)|
|Mr. Joshua H. Levine ,
Chief Exec. Officer, Pres and Director
|Mr. Gregory E. Lichtwardt ,
Chief Financial Officer and Exec. VP of Operations
|Ms. Alaleh Nouri ,
Sr. VP, Gen. Counsel and Corp. Sec.
|Ms. Kelly J. Londy ,
Chief Commercial Officer and Exec. VP
|Mr. Derek A. Bertocci ,
|Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|